Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Endocrine-Related Cancer|May 27, 2006
p53 and breast cancer, an updateMarc Lacroix, Robert-Alain Toillon, Guy LeclercqInternational Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Estrogens decrease gamma-ray-induced senescence and maintain cell cycle progression in breast cancer cells independently of p53Robert-Alain Toillon, Nicolas Magné, Ioanna Laïos, et al.Breast Cancer Research and Treatment|February 6, 2004
Relevance of breast cancer cell lines as models for breast tumours: an updateMarc Lacroix, Guy LeclercqBreast Cancer Research and Treatment|March 9, 2005
The "portrait" of hereditary breast cancerMarc Lacroix, Guy LeclercqJournal of Molecular Endocrinology|August 19, 2007
Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cellsDenis Nonclercq, Fabrice Journé, Ioanna Laïos, et al.The Journal of Steroid Biochemistry and Molecular Biology|April 29, 2005
Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cellsIoanna Laïos, Fabrice Journé, Denis Nonclercq, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 16, 2003
Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogensIoanna Laïos, Fabrice Journe, Guy Laurent, et al.Current Cancer Drug Targets|February 16, 2006
Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cellsGuy Leclercq, Marc Lacroix, Ioanna Laïos, et al.Journal of Inorganic Biochemistry|February 2, 2010
A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell linesAnne Vessières, Cyril Corbet, Jan Martin Heldt, et al.Cancers|April 13, 2023
TrkA Co-Receptors: The Janus Face of TrkA?Sarah Trouvilliez, Chann Lagadec, Robert-Alain ToillonPageof 10